Differential regulation of ceramide synthase components LAC1 and LAG1 in Saccharomyces cerevisiae - PubMed (original) (raw)
Differential regulation of ceramide synthase components LAC1 and LAG1 in Saccharomyces cerevisiae
Marcin Kolaczkowski et al. Eukaryot Cell. 2004 Aug.
Abstract
In Saccharomyces cerevisiae, the essential ceramide synthase reaction requires the presence of one of a homologous pair of genes, LAG1 and LAC1. Mutants that lack both of these genes cannot produce ceramide and exhibit a striking synthetic growth defect. While the regulation of ceramide production is critical for the control of proliferation and for stress tolerance, little is known of the mechanisms that ensure proper control of this process. The data presented here demonstrate that the pleiotropic drug resistance (Pdr) regulatory pathway regulates the transcription of multiple genes encoding steps in sphingolipid biosynthesis, including LAC1. The zinc cluster transcriptional activators Pdr1p and Pdr3p bind to Pdr1p/Pdr3p-responsive elements (PDREs) in the promoters of Pdr pathway target genes. LAC1 contains a single PDRE in its promoter, but notably, LAG1 does not. Reporter gene, Northern blot, and Western blot assays indicated that the expression level of Lac1p is approximately three times that of Lag1p. Detailed analyses of the LAC1 promoter demonstrated that transcription of this gene is inhibited by the presence of the transcription factor Cbf1p and the anaerobic repressor Rox1p. LAG1 transcription was also elevated in cbf1Delta cells, indicating at least one common regulatory input. Although a hyperactive Pdr pathway altered the profile of sphingolipids produced, the loss of either LAC1 or LAG1 alone failed to produce further changes. Two other genes involved in sphingolipid biosynthesis (LCB2 and SUR2) were found to contain PDREs in their promoters and to be induced by the Pdr pathway. These data demonstrate extensive coordinate control of sphingolipid biosynthesis and multidrug resistance in yeast.
Figures
FIG. 1.
Biosynthesis of sphingolipids in S. cerevisiae. A simplified diagram listing key steps in sphingolipid synthesis is shown. Proteins known to be involved at each step are listed by genetic designation. Gene products that are responsive to Pdr pathway regulation are indicated in bold italics.
FIG. 2.
Northern blot analysis of LAC1 and LAG1 transcription. Total RNAs were prepared from the indicated strains, electrophoresed through formaldehyde-agarose gels, and transferred to a nylon membrane. 18S RNA was visualized by staining to ensure equal loading, and LAC1 or LAG1 transcripts were detected by probing the blot with 32P-labeled DNA fragments from each coding region. (A) LAC1 mRNA levels are shown with relevant genetic backgrounds indicated. Plasmids carrying wild-type PDR1 (pPDR1), PDR3 (pPDR3), or hyperactive PDR3 (pPDR3-11) are listed along with the empty vector control (pRS315). (B) LAG1 mRNA levels are shown.
FIG. 3.
Western blot analysis of HA-tagged Lac1p and Lag1p. Whole-cell protein extracts were prepared from the indicated strains, and equal amounts of each extract were electrophoresed by SDS-PAGE. Each strain contained a low-copy-number plasmid expressing a 3× HA-tagged form of either Lac1p (top) or Lag1p (bottom). Where indicated, a low-copy-number plasmid carrying hyperactive PDR3 (PDR3-11) or the empty vector (pRS315) was also present. After electrophoresis, the proteins were transferred to nitrocellulose and the membrane was probed with an anti-HA antibody. A monoclonal antibody directed against the vacuolar membrane protein Vph1p was used to ensure equal loading and transfer.
FIG. 4.
A single PDRE mediates Pdr pathway regulation of LAC1. Low-copy-number plasmids carrying either a wild-type LAC1 promoter fusion to lacZ (LAC1-lacZ) or a mutant promoter lacking the PDRE (mPDRE-LAC1-lacZ) were introduced into the strains listed at the bottom of the figure (relevant genetic markers are shown). An empty vector plasmid (pRS315) or the same vector carrying the hyperactive _PDR3_-11 allele were present where indicated. Transformants were grown to mid-log phase, and β-galactosidase activities were determined as described in Materials and Methods.
FIG. 5.
Pdr1p and Pdr3p bind to LAC1 PDRE in vitro. DNA fragments containing the PDRE region from either the wild-type LAC1 promoter (wt) or the site-directed mutant form (mPDRE) were radiolabeled with 32P as described in Materials and Methods. Each probe was incubated with no added proteins, with protein extracts from bacterial cells carrying an empty expression vector (vector only), or with the same vector expressing the DNA binding domain of Pdr1p or Pdr3p. Protein-DNA complexes were then treated with DNase I followed by electrophoresis through denaturing acrylamide-urea gels as described previously (32). The location of the PDRE (indicated to the left) was determined by comparison to a Maxam-Gilbert chemical cleavage reaction and restriction digestion (not shown).
FIG. 6.
Deletion mapping of the LAC1 promoter. A series of 5′ and internal promoter deletion derivatives of the LAC1-lacZ plasmid were generated. The solid lines indicate the extent of the promoter that remains in each construct. The name of each mutant construct is shown on the left side of the figure. A line drawing of the wild-type LAC1 promoter region is shown at the top with numbers referring to distances from the ATG codon. The dark gray boxes show the location of the putative Cbf1p binding sites, the white box corresponds to the PDRE, and the light gray box denotes the Rox1p binding site. The PDRE was altered by a site-directed mutation in pMK010303 and was precisely deleted from pMK0104-4. Each plasmid was transformed into isogenic wild-type (BY4742) or _rox1_Δ (BY4742 _rox1_Δ) cells, and β-galactosidase activities were assayed as described in the text.
FIG. 7.
Recombinant Rox1p binds to an element in the LAC1 promoter. DNase I protection analysis was used as described in the text. A purine-specific chemical cleavage reaction (AG) was used to locate the Rox1p binding site (shown to the left). DNase I digestion was carried out in the absence of added protein (no protein) or with increasing amounts of Rox1p (indicated at the top).
FIG. 8.
LAC1 and LAG1 expression control by Cbf1p and Rox1p. Low-copy-number plasmids containing the lacZ fusion genes listed were introduced into the indicated isogenic strains. Transformants were grown to mid-log phase and β-galactosidase activities were determined. (A) Expression of _LAC1_-lacZ fusion plasmids plotted on the same scale for comparison. (B) Expression of LAG1-lacZ plotted on an expanded scale to emphasize the observed change in gene expression.
FIG. 9.
LCB2 and SUR2 response to elevated Pdr pathway activity and _rox1_Δ. _LCB2_-lacZ and SUR2-lacZ fusions carried on low-copy-number plasmids were introduced into isogenic wild-type or _rox1_Δ strains along with an empty vector (pRS315) or the same plasmid carrying the hyperactive _PDR3_-11 allele. Transformants were grown and assayed for β-galactosidase activity as described in the text.
FIG. 10.
Pdr-dependent changes in sphingolipid and ceramide composition. Cells of the indicated genotype expressing either PDR3 or the hyperactive _PDR3_-11 allele were labeled with [3H]serine for 2 h at 30°C, lipids were extracted and deacylated, and sphingolipids and ceramides were analyzed by thin-layer chromatography. Mol% values for the indicated lipid species are indicated on the ordinate. (A) Relative abundance of IPC-C and IPC-D species; (B) composition of free ceramide species.
Similar articles
- Lag1p and Lac1p are essential for the Acyl-CoA-dependent ceramide synthase reaction in Saccharomyces cerevisae.
Schorling S, Vallée B, Barz WP, Riezman H, Oesterhelt D. Schorling S, et al. Mol Biol Cell. 2001 Nov;12(11):3417-27. doi: 10.1091/mbc.12.11.3417. Mol Biol Cell. 2001. PMID: 11694577 Free PMC article. - Yeast ceramide synthases, Lag1 and Lac1, have distinct substrate specificity.
Megyeri M, Prasad R, Volpert G, Sliwa-Gonzalez A, Haribowo AG, Aguilera-Romero A, Riezman H, Barral Y, Futerman AH, Schuldiner M. Megyeri M, et al. J Cell Sci. 2019 Jun 24;132(12):jcs228411. doi: 10.1242/jcs.228411. J Cell Sci. 2019. PMID: 31164445 Free PMC article. - The yeast zinc finger regulators Pdr1p and Pdr3p control pleiotropic drug resistance (PDR) as homo- and heterodimers in vivo.
Mamnun YM, Pandjaitan R, Mahé Y, Delahodde A, Kuchler K. Mamnun YM, et al. Mol Microbiol. 2002 Dec;46(5):1429-40. doi: 10.1046/j.1365-2958.2002.03262.x. Mol Microbiol. 2002. PMID: 12453227 - Regulation of Ergosterol Biosynthesis in Saccharomyces cerevisiae.
Jordá T, Puig S. Jordá T, et al. Genes (Basel). 2020 Jul 15;11(7):795. doi: 10.3390/genes11070795. Genes (Basel). 2020. PMID: 32679672 Free PMC article. Review. - Retrograde regulation of multidrug resistance in Saccharomyces cerevisiae.
Moye-Rowley WS. Moye-Rowley WS. Gene. 2005 Jul 18;354:15-21. doi: 10.1016/j.gene.2005.03.019. Gene. 2005. PMID: 15896930 Review.
Cited by
- Phenotype to genotype in Neurospora crassa: Association of the scumbo phenotype with mutations in the gene encoding ceramide C9-methyltransferase.
Bredeweg EL, McCluskey K, Baker SE. Bredeweg EL, et al. Curr Res Microb Sci. 2022 Feb 19;3:100117. doi: 10.1016/j.crmicr.2022.100117. eCollection 2022. Curr Res Microb Sci. 2022. PMID: 35909622 Free PMC article. - The Ceramide Synthase Subunit Lac1 Regulates Cell Growth and Size in Fission Yeast.
Flor-Parra I, Sabido-Bozo S, Ikeda A, Hanaoka K, Aguilera-Romero A, Funato K, Muñiz M, Lucena R. Flor-Parra I, et al. Int J Mol Sci. 2021 Dec 28;23(1):303. doi: 10.3390/ijms23010303. Int J Mol Sci. 2021. PMID: 35008733 Free PMC article. - Cytotoxicity of 1-deoxysphingolipid unraveled by genome-wide genetic screens and lipidomics in Saccharomyces cerevisiae.
Haribowo AG, Hannich JT, Michel AH, Megyeri M, Schuldiner M, Kornmann B, Riezman H. Haribowo AG, et al. Mol Biol Cell. 2019 Oct 15;30(22):2814-2826. doi: 10.1091/mbc.E19-07-0364. Epub 2019 Sep 11. Mol Biol Cell. 2019. PMID: 31509475 Free PMC article. - Centromeric non-coding RNA as a hidden epigenetic factor of the point centromere.
Ling YH, Yuen KWY. Ling YH, et al. Curr Genet. 2019 Oct;65(5):1165-1171. doi: 10.1007/s00294-019-00988-6. Epub 2019 May 9. Curr Genet. 2019. PMID: 31073666 Review.
References
- Balzi, E., W. Chen, S. Ulaszewski, E. Capieaux, and A. Goffeau. 1987. The multidrug resistance gene PDR1 from Saccharomyces cerevisiae. J. Biol. Chem. 262:16871-16879. - PubMed
- Boeke, J. D., F. Lacroute, and G. R. Fink. 1984. A positive selection for mutants lacking orotidine 5′-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance. Mol. Gen. Genet. 197:345-346. - PubMed
- Chung, N., C. Mao, J. Heitman, Y. A. Hannun, and L. M. Obeid. 2001. Phytosphingosine as a specific inhibitor of growth and nutrient import in Saccharomyces cerevisiae. J. Biol. Chem. 276:35614-35621. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases